0225 GMT - SGH's FY 2026 Ebit growth guide is roughly 5% below consensus, says UBS. "The moderated growth outlook likely reflects a drag from Beach and Coates, offset by MSD [mid-single-digit] Ebit growth at WesTrac and Boral," analysts at UBS say in a note. SGH's FY 2025 Ebit is broadly in line with UBS's and the market's expectations, they say. UBS has a buy rating and a A$60.00 target on the stock. SGH is down 11% at A$46.29. (rhiannon.hoyle@wsj.com; @RhiannonHoyle)
(END) Dow Jones Newswires
August 11, 2025 22:25 ET (02:25 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.